Loading interface...

Tachyra 150 MG Injection

Manufactured byCipla Ltd.
ContainsAmiodarone
Description

Tachyra 150 MG Injection is an antiarrhythmic medicine that is used to maintain normal heartbeats in patients with serious, life-threatening ventricular arrhythmias (rhythm disorders of the ventricles; the lower chambers of the heart). It is mainly used in patients who are not responding to the oral forms of this medicine.

Substitutes

List of substitutes for Tachyra 150 MG Injection

Amiodarone 150 MG Injection
Cipla Ltd.
Cordarone 150 MG Injection
Sanofi India Ltd.

Side effects

Major & minor side effects for Tachyra 150 MG Injection

  • Cough
  • Dizziness
  • Increased sensitivity of the skin to sunlight
  • Blurred vision
  • Trouble sleeping
  • Skin rash
  • Yellow colored eyes or skin
  • Headache
  • Constipation
  • Pain at the injection site
  • Decreased appetite or loss of appetite
  • Low blood pressure (hypotension)
  • Difficulty in breathing
  • Weakness of arms or legs
  • Uncontrolled body movements
  • Unusual tiredness and weakness

Uses of Tachyra 150 MG Injection

What is it prescribed for?

  • Arrhythmias
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Allergy

This medicine is not recommended for use if you have a known allergy to amiodarone or any other inactive ingredients present along with the formulation.

Cardiogenic shock

This medicine is not recommended for use in patients with cardiogenic shock due to the increased risk of worsening the patient's condition.

Heart block greater than first degree

This medicine is not recommended for use in patients with second or third-degree heart block due to the risk of worsening of the patient's condition.

Sinus Bradycardia

This medicine is not recommended for use in patients with sinus bradycardia (a type of slow heartbeat) due to the increased risk of worsening the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
General warnings

Pulmonary toxicity

This medicine may cause severe lung injury which includes hypersensitivity pneumonitis and Interstitial Pneumonitis. Discontinue the treatment as soon as these symptoms appear until the exact cause is identified.

Worsened arrhythmia

This medicine may cause exacerbation of the arrhythmias. This effect is more common in the patients being treated with other antiarrhythmic medicines or any changes in the dose. Close monitoring of potassium and magnesium levels are necessary while receiving this medicine. Any symptoms of heart palpitations should be reported to the doctor.

Use in children

This medicine is not recommended for use in patients less than 18 years of age since the safety and efficacy of use are not clinically established.

Liver impairment

This medicine should be used with extreme caution in patients with liver impairment due to the increased risk of severe adverse effects. Regular monitoring of liver function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Visual impairment

This medicine should be used with caution in patients suffering from optic neuropathy, neuritis or any visual defects due to the increased risk of visual impairment changes. Regular ophthalmological examinations should be done while receiving this medicine.

Driving and operating machinery

This medicine may cause symptoms such as dizziness, visual disturbances, fainting, weakness, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during or immediately after receiving this medicine.

Missed Dose

Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Budesonide

Azole antifungal agents

Theophylline

Azithromycin

Dutasteride

Alfuzosin

Efavirenz

Codeine

Digoxin

Clobazam

Docetaxel

Clopidogrel

Diclofenac

Asenapine

Capreomycin

Adenosine

Crizotinib

Disease interactions

Electrolyte imbalance

Electrolyte imbalance can alter the therapeutic effectiveness of antiarrhythmic agents. The increase in potassium levels may increase the toxic effects of antiarrhythmic medicines. The baseline of these electrolytes should be obtained before initiation of the therapy and any changes in the values should be reported to the doctor.

Liver impairment

This medicine should be used with caution in patients suffering from liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Neurological disorders

This medicine should be used with caution in patients suffering from neurologic dysfunction due to the increased risk of worsening the patient's condition. Report any adverse effects like dizziness, tremor, and involuntary movements, etc. to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Cardiovascular diseases

This medicine should be used with caution in patients suffering from cardiovascular disorders such as hypotension (low blood pressure) and CHF ( congestive heart failure) Close monitoring of heart function is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Thyroid Dysfunction

This medicine should be used with caution in patients with thyroid dysfunction due to the increased risk of worsening of the patient's condition. Close monitoring of thyroid function is necessary while receiving this medicine. Any symptoms of irritability, irregular heartbeats, nervousness, and weight loss should be reported to the doctor. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine works by reducing the hyperactivity of the heart muscles.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Group III antiarrhythmics

Schedule

Schedule H

[Internet]. Accessdata.fda.gov. 2019 [cited 25 February 2019]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022325s002lbl.pdf

[Internet]. Medicines.org.uk. 2019 [cited 25 February 2019]. Available from:

https://www.medicines.org.uk/emc/files/pil.3453.pdf

DailyMed - Amiodarone Hydrochloride injection, solution [Internet]. Dailymed.nlm.nih.gov. 2020 [cited 15 April 2020]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=51772745-9ea9-42cd-97e6-7266f41ae3ca

Amiodarone - DrugBank [Internet]. Drugbank.ca. 2020 [cited 15 April 2020]. Available from:

https://www.drugbank.ca/drugs/DB01118
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 15 Apr 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.